Last update 09 Nov 2024

Nefopam/Acetaminophen

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
METAPAIN
Target
COX
Mechanism
COX inhibitors(Cyclooxygenases inhibitors)
Therapeutic Areas
Nervous System Diseases
Active Indication-
Inactive Indication
Acute Pain
Originator Organization
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
Active Organization-
Inactive Organization
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H20ClNO
InChIKeyCNNVSINJDJNHQK-UHFFFAOYSA-N
CAS Registry23327-57-3
View All Structures (2)

Related

2
Clinical Trials associated with Nefopam/Acetaminophen
NCT04622813 / CompletedPhase 3IIT
The Effect of Intraoperative Nefopam, Ketoprofen and Paracetamol Combination vs Ketoprofen and Paracetamol Combination on Postoperative Morphine Requirements After Laparoscopic Cholecystectomy: A Randomized, Controlled Trial
NCT04622735 / CompletedPhase 3
A Comparative, Randomized, Double-blind, 3-arm Parallel, Phase III Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Nefopam/Paracetamol Taken Orally in Moderate to Severe Pain After Impacted Third Molar Extraction
100 Clinical Results associated with Nefopam/Acetaminophen
Login to view more data
100 Translational Medicine associated with Nefopam/Acetaminophen
Login to view more data
100 Patents (Medical) associated with Nefopam/Acetaminophen
Login to view more data
100 Deals associated with Nefopam/Acetaminophen
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute PainPhase 3
BE
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
22 Feb 2020
Acute PainPhase 3
FR
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
22 Feb 2020
Acute PainPhase 3
HU
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
22 Feb 2020
Acute PainPhase 3
RU
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
22 Feb 2020
Acute PainPhase 3
GB
Unither Pharmaceuticals SASUUnither Pharmaceuticals SASU
22 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free